Marsh & McLennan Companies (NYSE:MMC) Price Target Raised to $238.00 at UBS Group

Marsh & McLennan Companies (NYSE:MMCFree Report) had its price objective increased by UBS Group from $236.00 to $238.00 in a research report report published on Monday morning, Benzinga reports. The firm currently has a buy rating on the financial services provider’s stock.

Several other equities analysts have also commented on the company. Wells Fargo & Company increased their price objective on Marsh & McLennan Companies from $212.00 to $213.00 and gave the company an equal weight rating in a research report on Friday. Royal Bank of Canada increased their price objective on Marsh & McLennan Companies from $208.00 to $210.00 and gave the company a sector perform rating in a research report on Friday. Jefferies Financial Group increased their price objective on Marsh & McLennan Companies from $197.00 to $208.00 and gave the company a hold rating in a research report on Friday. Keefe, Bruyette & Woods increased their price objective on Marsh & McLennan Companies from $185.00 to $188.00 and gave the company an underperform rating in a research report on Wednesday, April 10th. Finally, Evercore ISI raised their price target on Marsh & McLennan Companies from $212.00 to $218.00 and gave the stock an outperform rating in a research report on Thursday, April 11th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have given a buy rating to the stock. According to MarketBeat, Marsh & McLennan Companies currently has an average rating of Hold and an average price target of $207.69.

View Our Latest Report on Marsh & McLennan Companies

Marsh & McLennan Companies Price Performance

Shares of NYSE MMC opened at $201.43 on Monday. The firm has a market capitalization of $99.41 billion, a P/E ratio of 25.56, a P/E/G ratio of 3.39 and a beta of 0.90. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.97. The stock’s 50-day simple moving average is $202.96 and its two-hundred day simple moving average is $196.98. Marsh & McLennan Companies has a twelve month low of $171.47 and a twelve month high of $209.20.

Marsh & McLennan Companies (NYSE:MMCGet Free Report) last announced its earnings results on Thursday, April 18th. The financial services provider reported $2.89 earnings per share for the quarter, topping analysts’ consensus estimates of $2.80 by $0.09. The business had revenue of $6.50 billion for the quarter, compared to analyst estimates of $6.38 billion. Marsh & McLennan Companies had a return on equity of 34.14% and a net margin of 16.84%. The company’s quarterly revenue was up 9.7% compared to the same quarter last year. During the same period in the prior year, the company earned $2.53 EPS. As a group, equities analysts anticipate that Marsh & McLennan Companies will post 8.64 EPS for the current fiscal year.

Marsh & McLennan Companies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Thursday, April 4th will be issued a $0.71 dividend. This represents a $2.84 annualized dividend and a yield of 1.41%. The ex-dividend date of this dividend is Wednesday, April 3rd. Marsh & McLennan Companies’s dividend payout ratio (DPR) is currently 36.04%.

Insiders Place Their Bets

In other Marsh & McLennan Companies news, CFO Mark C. Mcgivney sold 12,494 shares of the stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $200.79, for a total value of $2,508,670.26. Following the completion of the sale, the chief financial officer now owns 33,678 shares in the company, valued at approximately $6,762,205.62. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, CFO Mark C. Mcgivney sold 12,494 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $200.79, for a total value of $2,508,670.26. Following the completion of the transaction, the chief financial officer now owns 33,678 shares in the company, valued at approximately $6,762,205.62. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Martine Ferland sold 9,128 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $201.63, for a total value of $1,840,478.64. Following the completion of the transaction, the chief executive officer now owns 9,979 shares of the company’s stock, valued at approximately $2,012,065.77. The disclosure for this sale can be found here. In the last 90 days, insiders sold 36,751 shares of company stock worth $7,448,163. 0.30% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in shares of Marsh & McLennan Companies by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 43,798,034 shares of the financial services provider’s stock valued at $8,298,414,000 after purchasing an additional 180,128 shares during the period. FMR LLC increased its position in Marsh & McLennan Companies by 0.3% during the 3rd quarter. FMR LLC now owns 19,423,136 shares of the financial services provider’s stock valued at $3,696,223,000 after buying an additional 61,408 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in Marsh & McLennan Companies by 32.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,243,245 shares of the financial services provider’s stock valued at $1,940,789,000 after buying an additional 2,526,701 shares in the last quarter. Ameriprise Financial Inc. increased its position in Marsh & McLennan Companies by 0.4% during the 3rd quarter. Ameriprise Financial Inc. now owns 8,278,659 shares of the financial services provider’s stock valued at $1,575,881,000 after buying an additional 31,821 shares in the last quarter. Finally, Morgan Stanley increased its position in Marsh & McLennan Companies by 2.5% during the 3rd quarter. Morgan Stanley now owns 6,145,046 shares of the financial services provider’s stock valued at $1,169,403,000 after buying an additional 150,655 shares in the last quarter. Hedge funds and other institutional investors own 87.99% of the company’s stock.

About Marsh & McLennan Companies

(Get Free Report)

Marsh & McLennan Companies, Inc, a professional services company, provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. It operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions, as well as insurance and reinsurance broking, strategic advisory services, and analytics solutions, and insurance program management services.

Further Reading

Analyst Recommendations for Marsh & McLennan Companies (NYSE:MMC)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.